Osteoarthritis
(OA)
is
a
common
bone
and
joint
disease
characterized
by
degeneration.
The
imbalance
between
the
synthesis
breakdown
of
chondrocytes
major
contributing
factor
to
OA.
A
potential
treatment
for
OA
could
involve
targeting
degenerative
changes
in
cartilage
tissue
degradation.
Previous
studies
have
shown
close
relationship
autophagy
regulation
chondrocyte
breakdown.
Activation
has
been
found
alleviate
degeneration
tissue.
Currently,
primary
focus
osteoarthritis
symptom
relief,
as
there
no
effective
medication
halt
progression.
In
previous
studies,
luteolin,
flavonoid
Chinese
herbal
medicine,
activate
reduce
expression
MMP1
ADAMTS-5.
this
study,
an
vitro
model
was
created
using
stimulated
IL-1β,
different
concentrations
luteolin
were
used
treatment.
Treatment
with
significantly
increased
levels
factors
Aggrecan
Collagen
II,
while
decreasing
decomposition
MMP-13
Furthermore,
when
inhibited
Chloroquine,
imbalances
anabolic
catabolic
activities
induced
IL-1β
reversed.
vivo
knee
medial
meniscal
instability
(DMM),
administered
therapeutic
schedule.
After
12
weeks,
tissues
mice
collected
analysis.
Immunofluorescence
immunohistochemical
staining
showed
decrease
level
P62
increase
Beclin-1
tissues.
Additionally,
wear
joints
relieved
safranin
O
fast
green
staining.
findings
our
study
highlight
significant
role
effectively
reversing
IL-1β.
Our
results
strongly
indicate
that
be
developed
novel
agent
osteoarthritis,
offering
promising
prospects
future
drug
development.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(7), P. 3417 - 3443
Published: April 26, 2024
Abstract
Natural
products
are
closely
associated
with
human
health.
Luteolin
(LUT),
a
flavonoid
polyphenolic
compound,
is
widely
found
in
fruits,
vegetables,
flowers,
and
herbs.
It
noteworthy
that
LUT
exhibits
variety
of
beneficial
pharmacological
properties
holds
significant
potential
for
clinical
applications,
particularly
antitumor,
anti‐convulsion,
diabetes
control,
anti‐inflammatory,
neuroprotection,
anti‐oxidation,
anti‐cardiovascular,
other
aspects.
The
mechanism
action
has
been
partially
elucidated,
including
the
mediation
NF‐κB,
toll‐like
receptor,
MAPK,
Wnt/β‐catenin,
PI3K/Akt,
AMPK/mTOR,
Nrf‐2,
among
others.
review
aimed
to
comprehensively
consolidate
essential
information
on
natural
sources,
effects,
therapeutic
preventive
potential,
as
well
mechanisms
LUT.
objective
establish
theoretical
basis
continued
development
application
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
176, P. 116909 - 116909
Published: June 8, 2024
Lung
cancer
is
a
prevalent
malignant
tumor
and
leading
cause
of
cancer-related
fatalities
globally.
However,
current
treatments
all
have
limitations.
Therefore,
there
an
urgent
need
to
identify
readily
available
therapeutic
agent
counteract
lung
development
progression.
Luteolin
flavonoid
derived
from
vegetables
herbs
that
possesses
preventive
effects
on
various
cancers.
With
the
goal
providing
new
directions
for
treatment
cancer,
we
review
here
recent
findings
luteolin
so
as
provide
ideas
anti-lung
drugs.
The
search
focused
studies
published
between
January
1995
2024
explored
use
in
cancer.
A
comprehensive
literature
was
conducted
SCOPUS,
Google
Scholar,
PubMed,
Web
Science
databases
using
keywords
"luteolin"
"lung
cancer."
By
collecting
previous
literature,
found
has
multiple
mechanisms
effects,
including
promotion
apoptosis
cells;
inhibition
cell
proliferation,
invasion
metastasis;
modulation
immune
responses.
In
addition,
it
can
be
used
adjuvant
radio-chemotherapy
helps
ameliorate
complications.
This
summarizes
structure,
natural
sources,
physicochemical
properties
pharmacokinetics
luteolin,
focuses
mechanism
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
The
Prunella
vulgaris
L.
(PVL)
and
Taraxacum
mongolicum
Hand.-Mazz.
(TH)
herb
pair,
which
is
commonly
used
in
traditional
Chinese
medicine
(TCM),
has
been
applied
for
the
treatment
of
breast
cancer.
Although
its
efficacy
validated,
synergistic
anti-breast
cancer
compound
combinations
within
this
pair
their
underlying
mechanisms
action
remain
unclear.
This
study
aimed
to
identify
validate
PVL-TH
using
large-scale
biomedical
data,
artificial
intelligence
experimental
methods.
first
step
was
investigate
effects
various
PVL
TH
extracts
vitro
cellular
assays
most
effective
superior
extracts.
These
were
subjected
liquid
chromatography-mass
spectrometry
(LC-MS)
analysis
constituent
compounds.
A
deep
learning-based
prediction
model,
DeepMDS,
predict
multi-compound
combinations.
predicted
experimentally
validated
at
actual
content
ratios
found
Preliminary
bioinformatics
analyses
conducted
explore
these
We
also
compared
from
different
geographical
origins
analyzed
contents
compounds
assess
representation
anti-tumor
effect
corresponding
TCM.
results
revealed
that
LC-MS
identified
27
21
(50%
ethanol
extracts)
TH,
respectively.
Based
on
compounds,
DeepMDS
model
such
as
F973
(caffeic
acid,
rosmarinic
p-coumaric
esculetin),
T271
(chlorogenic
cichoric
caffeic
acid),
T1685
scopoletin)
single
PVL,
combinations,
concentrations
extracts,
demonstrated
activity
could
regulate
tumor-related
pathways
synergistically,
inhibiting
tumor
cell
growth,
inducing
apoptosis,
blocking
cycle
progression.
Furthermore,
concentration
ratio
total
closely
associated
with
origins.
combination
represent
pair.
provides
insights
into
exploring
representative
complex
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 2507 - 2528
Published: March 1, 2024
Background:
Cancer
continues
to
be
a
prominent
issue
in
the
field
of
medicine,
as
demonstrated
by
recent
studies
emphasizing
significant
role
autophagy
development
cancer.
Traditional
Chinese
Medicine
(TCM)
provides
variety
anti-tumor
agents
capable
regulating
autophagy.
However,
clinical
application
autophagy-modulating
compounds
derived
from
TCM
is
impeded
their
restricted
water
solubility
and
bioavailability.
To
overcome
this
challenge,
utilization
nanotechnology
has
been
suggested
potential
solution.
Nonetheless,
current
body
literature
on
nanoparticles
delivering
TCM-derived
for
cancer
treatment
limited,
lacking
comprehensive
summaries
detailed
descriptions.
Methods:
Up
November
2023,
research
study
was
conducted
gather
relevant
data
using
databases,
including
PubMed,
ScienceDirect,
Springer
Link,
Web
Science,
CNKI.
The
keywords
utilized
investigation
included
"autophagy",
"nanoparticles",
"traditional
medicine"
"anticancer".
Results:
This
review
analysis
overcoming
delivery
challenges
enhancing
anti-cancer
properties
TCM.
evaluation
based
synthesis
different
classes
TCM,
mechanisms
action
treatment,
benefits
reported
various
scholarly
sources.
findings
indicate
that
shows
availability
thereby
opening
up
plethora
therapeutic
avenues.
Conclusion:
Nanotechnology
enhance
efficacy
traditional
through
regulation
Keywords:
autophagy,
nano-delivery,
anti-cancer,
medicine
ABSTRACT
Luteolin
is
widely
distributed
phytochemical,
a
flavonoid,
in
kingdom
plantae.
with
potential
antioxidant
activity
prevent
ROS‐induced
damages
and
reduce
oxidative
stress
which
mainly
responsible
pathogenesis
of
many
diseases.
Several
chemo
preventive
activities
therapeutic
benefits
are
associated
luteolin.
prevents
cancer
via
modulation
numerous
pathways,
that
is,
by
inactivating
proteins;
such
as
procaspase‐9,
CDC2
cyclin
B
or
upregulation
caspase‐9
caspase‐3,
cytochrome
C,
A,
CDK2,
APAF‐1,
turn
inducing
cell
cycle
arrest
well
apoptosis.
It
also
enhances
phosphorylation
p53
expression
level
p53‐targeted
downstream
gene.
By
Increasing
BAX
protein
expression;
decreasing
VEGF
Bcl‐2
it
can
initiate
stimulate
mitochondrial‐modulated
functions
to
cause
cellular
death.
levels
p‐Akt,
p‐EGFR,
p‐Erk1/2,
p‐STAT3.
plays
positive
role
against
cardiovascular
disorders
improving
cardiac
function,
the
release
inflammatory
cytokines
enzymes,
prevention
fibrosis
hypertrophy;
CTGF,
TGFβ1,
ANP,
Nox2,
Nox4
gene
expressions.
Meanwhile
suppresses
TGFβ1
JNK.
helps
fight
diabetes
inhibition
alpha‐glucosidase
ChE
activity.
catalase,
superoxide
dismutase,
GS4.
improve
blood
glucose,
insulin,
HOMA‐IR,
HbA1c
levels.
This
review
an
attempt
elaborate
molecular
targets
luteolin
its
modulating
irregularities
pathways
overcome
severe
outcomes
during
diseases
including
cancer,
disorders,
diabetes,
obesity,
inflammation,
Alzheimer's
disease,
Parkinson's
hepatic
renal
brain
injury,
asthma.
As
has
enormous
benefits,
could
be
candidate
future
drug
development
strategies.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 20, 2025
Luteolin,
a
flavonoid
present
in
botanical
drugs,
plants,
and
dietary
sources,
has
demonstrated
anticancer
properties
against
various
tumors,
yet
its
role
diffuse
large
B-cell
lymphoma
(DLBCL)
remains
unclear.
This
study
aimed
to
uncover
the
molecular
mechanism
of
luteolin
DLBCL
treatment
using
combination
vitro
vivo
experiments
computational
analysis.
Human
cell
lines
U2932
OCI-LY10
were
utilized
assess
luteolin's
impact
on
growth,
apoptosis,
cycle
progression,
modulation
JAK2/STAT3
pathway
proteins.
In
vivo,
tumor-bearing
nude
mice
model
was
employed
evaluate
antitumor
efficacy
effects
protein
expression.
Additionally,
dynamics
simulations
conducted
explore
interaction
between
JAK2.
The
findings
revealed
that
significantly
suppressed
proliferation,
induced
arrested
at
G2/M
phase
both
lines.
mouse
model,
effectively
inhibited
tumor
growth
downregulated
expression
phosphorylated
JAK2
STAT3
without
altering
total
levels
STAT3.
Computational
analysis
indicated
stable
binding
Collectively,
these
results
suggest
anti-DLBCL
activity
may
be
mediated
through
regulation
signaling
pathway,
positioning
it
as
potential
therapeutic
agent
for
DLBCL.
ABSTRACT
Luteolin
(LUT)
has
been
suggested
as
an
inhibitor
of
osteoporosis
(OP).
This
investigation
examines
the
pivotal
role
miR‐125b‐5p/SIRT3/AMPK/mTOR
pathway
in
mediating
luteolin‐induced
effects
on
OP.
Mesenchymal
stem
cells
derived
from
bone
marrow
(BMSCs)
were
exposed
to
dexamethasone
(DEX)
create
vitro
model
Following
treatment
with
luteolin,
levels
miR‐125b‐5p
and
SIRT3
quantified
using
reverse
transcription
polymerase
chain
reaction.
Moreover,
SIRT3,
AMPK,
mTOR
protein
levels,
osteogenesis
(OPN,
Runx2,
OSX,
OCN),
autophagy
(p62,
ATG5,
LC3,
BECN1)
evaluated
ELISA.
Additionally,
specific
mimics
siRNA
constructed
overexpress
or
downregulate
SIRT3.
Furthermore,
animal
models
DEX‐induced
OP
assess
LUT
at
doses
50
100
mg/kg/day
histology,
stereology,
biochemistry,
expression
miR‐125b‐5p,
SIRT3/AMPK/mTOR
axis,
markers
autophagy.
The
findings
revealed
that
suppressed
expression,
overexpressed
downregulated
BMSCs
compared
DEX
(
p
‐value
<
0.01).
Interestingly,
restored
for
0.001).
overexpression
downregulation
inhibited
therapeutic
properties.
In
animals,
improved
histology
0.05)
while
overexpressing
AMPK
RUNX2,
OPN,
OCN
improved,
was
enhanced
LUT‐treated
rats.
current
could
promote
improve
via
activation
through
pathway.
Hereditas,
Journal Year:
2025,
Volume and Issue:
162(1)
Published: April 21, 2025
Abstract
Background
Weiqi
Decoction
(WQD)
is
an
empirical
prescription
traditionally
used
in
China
for
the
treatment
of
precancerous
gastric
cancer
(GC)
lesions.
This
study
aimed
to
elucidate
potential
pharmacological
mechanisms
WQD
GC
therapy.
Methods
Active
ingredients,
corresponding
targets,
and
GC-related
genes
were
identified
using
public
databases.
A
protein–protein
interaction
(PPI)
network
was
constructed
via
STRING
database,
functional
enrichment
analyses
conducted
DAVID
platform.
Gene
expression
survival
performed
GEPIA
database.
Molecular
docking
with
AutoDock
Vina
visualized
PyMOL.
The
effects
on
cell
viability,
proliferation,
migration,
invasion
evaluated
through
CCK-8,
colony
formation,
Transwell
assays.
Results
contained
43
active
ingredients
targeting
751
genes,
including
458
targets.
Quercetin,
luteolin,
kaempferol
as
key
compounds.
PPI
analysis
revealed
nine
core
TP53
SRC
,
which
may
mediate
anti-GC
WQD.
GO
indicated
involvement
726
biological
processes,
91
cellular
components,
177
molecular
functions,
while
KEGG
pathway
suggested
modulation
AGE-RAGE,
PI3K-Akt,
HIF-1
signaling
pathways.
database
confirmed
that
EP300
HSP90AA1
HSP90AB1
highly
expressed
GC.
demonstrated
strong
binding
affinities
between
compounds
In
vitro
experiments
further
validated
extract
inhibited
invasion.
Conclusion
exhibits
therapeutic
against
by
regulating
multiple
targets
These
findings
provide
mechanistic
insights
into
actions
treatment.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(9), P. 4353 - 4385
Published: July 3, 2024
Autophagy
and
endoplasmic
reticulum
(ER)
stress
are
conserved
processes
that
generally
promote
survival,
but
can
induce
cell
death
when
physiological
thresholds
crossed.
The
pro-survival
aspects
of
these
exploited
by
cancer
cells
for
tumor
development
progression.
Therefore,
anticancer
drugs
targeting
autophagy
or
ER
to
and/or
block
the
being
investigated
extensively.
Consistently,
several
phytochemicals
have
been
reported
exert
their
effects
modulating
stress.
Various
(e.g.,
celastrol,
curcumin,
emodin,
resveratrol,
among
others)
activate
unfolded
protein
response
stress-mediated
apoptosis
through
different
pathways.
Similarly,
various
mechanisms
(namely
mechanistic
target
Rapamycin
[mTOR]
inhibition).
However,
phytochemical-induced
function
either
as
a
cytoprotective
mechanism
programmed
type
II.
Interestingly,
at
times,
same
phytochemical
6-gingerol,
shikonin,
II
depending
on
cellular
contexts,
such
type.
Although
there
is
well-documented
interplay
between
stress,
only
one-way
modulation
was
noted
with
some
(carnosol,
capsaicin,
cryptotanshinone,
guangsangon
E,
kaempferol,
δ-tocotrienol):
stress-dependent
autophagy.
Plant
extracts
sources
potent
while
numerous
in
preclinical
clinical
studies,
search
novel
ongoing
from
plant
used
traditional
medicine
Origanum
majorana).
Nonetheless,
translation
phytochemicals,
promising
avenue
therapeutics,
hindered
limitations
need
be
addressed
future
studies.